These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7680253)

  • 1. Epitopes of human immunodeficiency virus regulatory proteins tat, nef and rev are expressed in skin in atopic dermatitis.
    Schuurman HJ; Joling P; van Wichen DF; Tobin D; van der Putte SC
    Int Arch Allergy Immunol; 1993; 100(2):107-14. PubMed ID: 7680253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitopes of human immunodeficiency virus regulatory proteins tat, nef, and rev are expressed in normal human tissue.
    Parmentier HK; van Wichen DF; Meyling FH; Goudsmit J; Schuurman HJ
    Am J Pathol; 1992 Nov; 141(5):1209-16. PubMed ID: 1279980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.
    Reiss P; de Wolf F; Kuiken CL; de Ronde A; Dekker J; Boucher CA; Debouck C; Lange JM; Goudsmit J
    J Acquir Immune Defic Syndr (1988); 1991; 4(2):165-72. PubMed ID: 1898969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes.
    Hinkula J; Svanholm C; Schwartz S; Lundholm P; Brytting M; Engström G; Benthin R; Glaser H; Sutter G; Kohleisen B; Erfle V; Okuda K; Wigzell H; Wahren B
    J Virol; 1997 Jul; 71(7):5528-39. PubMed ID: 9188627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.
    Malm M; Rollman E; Ustav M; Hinkula J; Krohn K; Wahren B; Blazevic V
    Viral Immunol; 2005; 18(4):678-88. PubMed ID: 16359234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine.
    Blazevic V; Männik A; Malm M; Sikut R; Valtavaara M; Toots U; Ustav M; Krohn K
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):667-77. PubMed ID: 16831091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation.
    Sremac M; Stuart ES
    BMC Biotechnol; 2010 Jul; 10():54. PubMed ID: 20642814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals.
    Addo MM; Altfeld M; Rosenberg ES; Eldridge RL; Philips MN; Habeeb K; Khatri A; Brander C; Robbins GK; Mazzara GP; Goulder PJ; Walker BD;
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1781-6. PubMed ID: 11172028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human Fab antibody fragments to HIV-1 Rev and Tat regulatory proteins: direct selection from a combinatorial phage display library.
    Pilkington GR; Duan L; Zhu M; Keil W; Pomerantz RJ
    Mol Immunol; 1996; 33(4-5):439-50. PubMed ID: 8676895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to recombinant HIV-1 vif, tat, and nef proteins in human sera.
    Wieland U; Kühn JE; Jassoy C; Rübsamen-Waigmann H; Wolber V; Braun RW
    Med Microbiol Immunol; 1990; 179(1):1-11. PubMed ID: 2184337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation in rhesus macaques of Tat and rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08.
    Verrier B; Le Grand R; Ataman-Onal Y; Terrat C; Guillon C; Durand PY; Hurtrel B; Aubertin AM; Sutter G; Erfle V; Girard M
    DNA Cell Biol; 2002 Sep; 21(9):653-8. PubMed ID: 12396607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia.
    Ranki A; Nyberg M; Ovod V; Haltia M; Elovaara I; Raininko R; Haapasalo H; Krohn K
    AIDS; 1995 Sep; 9(9):1001-8. PubMed ID: 8527071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.
    Schneider T; Harthus HP; Hildebrandt P; Niedrig M; Bröker M; Weigelt W; Beck A; Pauli G
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):37-44. PubMed ID: 1707640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased number of immunoreactive nerve fibers in atopic dermatitis.
    Tobin D; Nabarro G; Baart de la Faille H; van Vloten WA; van der Putte SC; Schuurman HJ
    J Allergy Clin Immunol; 1992 Oct; 90(4 Pt 1):613-22. PubMed ID: 1383306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell epitopes in HIV-1 Tat and Rev proteins colocalize with T-cell epitopes and with functional domains.
    Tähtinen M; Ranki A; Valle SL; Ovod V; Krohn K
    Biomed Pharmacother; 1997; 51(10):480-7. PubMed ID: 9863510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTL responses to regulatory proteins Tat and Rev in HIV-1 B'/C virus-infected individuals.
    Jia MM; Hong KX; Chen JP; Liu HW; Liu S; Zhang XQ; Zhao HJ; Shao YM
    Biomed Environ Sci; 2008 Aug; 21(4):314-8. PubMed ID: 18837295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis.
    Ohki O; Yokozeki H; Katayama I; Umeda T; Azuma M; Okumura K; Nishioka K
    Br J Dermatol; 1997 Jun; 136(6):838-45. PubMed ID: 9217814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for CTL-mediated selection of Tat and Rev mutants after the onset of the asymptomatic period during HIV type 1 infection.
    Guillon C; Stankovic K; Ataman-Onal Y; Biron F; Verrier B
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1283-92. PubMed ID: 17209772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rationale behind a vaccine based on multiple HIV antigens.
    Rollman E; Bråve A; Boberg A; Gudmundsdotter L; Engström G; Isaguliants M; Ljungberg K; Lundgren B; Blomberg P; Hinkula J; Hejdeman B; Sandström E; Liu M; Wahren B
    Microbes Infect; 2005 Nov; 7(14):1414-23. PubMed ID: 16257558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.